insulin-like growth factor num igf num igf binding protein num igfbp num breast cancer risk pooled individual data analysis num prospective studies summary background insulin-like growth factor num igf num stimulates mitosis inhibits apoptosis published results shown association circulating igf num breast-cancer risk unclear relationship consistent modified igf binding protein num igfbp num menopausal status oestrogen receptor status factors relationship igf num igfbp num breast-cancer risk factors unclear endogenous hormones breast cancer collaborative group established analyse pooled individual data prospective studies increase precision estimated associations endogenous hormones breast-cancer risk methods individual data prediagnostic igf num igfbp num concentrations obtained num prospective studies num countries associations igf num risk factors breast cancer controls examined calculating geometric concentrations categories factors odds ratios ors num cis breast cancer increasing igf num concentrations estimated conditional logistic regression num cases num matched controls stratification study age baseline date baseline statistical tests two-sided num num considered significant findings igf num concentrations adjusted age positively height age pregnancy inversely age menarche years menopause higher moderately overweight women moderate alcohol consumers women breast cancer women highest versus lowest igf num concentration num num ci num num num num num num association altered adjusting igfbp num vary significantly menopausal status blood collection ors difference igf num concentration highest lowest num num ci num num num num oestrogen-receptor-positive tumours num num num num num oestrogen-receptor-negative tumours heterogeneity num num interpretation circulating igf num positively breast-cancer risk association substantially modified igfbp num differ markedly menopausal status confined oestrogen-receptor-positive tumours funding cancer research uk 
